178 related articles for article (PubMed ID: 15716060)
21. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
[TBL] [Abstract][Full Text] [Related]
22. Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.
Zhao Y; Cao X; Guo M; Wang X; Yu T; Ye L; Han L; Hei L; Tao W; Tong Y; Xu Y; Zhong J
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111563
[TBL] [Abstract][Full Text] [Related]
23. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.
Meyer K; Basu A; Ray R
Virology; 2000 Oct; 276(1):214-26. PubMed ID: 11022009
[TBL] [Abstract][Full Text] [Related]
24. A system for functional analysis of Ebola virus glycoprotein.
Takada A; Robison C; Goto H; Sanchez A; Murti KG; Whitt MA; Kawaoka Y
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14764-9. PubMed ID: 9405687
[TBL] [Abstract][Full Text] [Related]
25. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.
Emi N; Friedmann T; Yee JK
J Virol; 1991 Mar; 65(3):1202-7. PubMed ID: 1847450
[TBL] [Abstract][Full Text] [Related]
26. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.
Douam F; Dao Thi VL; Maurin G; Fresquet J; Mompelat D; Zeisel MB; Baumert TF; Cosset FL; Lavillette D
Hepatology; 2014 Mar; 59(3):776-88. PubMed ID: 24038151
[TBL] [Abstract][Full Text] [Related]
27. Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype.
Burioni R; Matsuura Y; Mancini N; Tani H; Miyamura T; Varaldo PE; Clementi M
J Virol; 2002 Nov; 76(22):11775-9. PubMed ID: 12388741
[TBL] [Abstract][Full Text] [Related]
28. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Bartz SR; Vodicka MA
Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
[TBL] [Abstract][Full Text] [Related]
29. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.
Dubuisson J; Hsu HH; Cheung RC; Greenberg HB; Russell DG; Rice CM
J Virol; 1994 Oct; 68(10):6147-60. PubMed ID: 8083956
[TBL] [Abstract][Full Text] [Related]
30. Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin.
Kaimori A; Kanto T; Kwang Limn C; Komoda Y; Oki C; Inoue M; Miyatake H; Itose I; Sakakibara M; Yakushijin T; Takehara T; Matsuura Y; Hayashi N
Virology; 2004 Jun; 324(1):74-83. PubMed ID: 15183055
[TBL] [Abstract][Full Text] [Related]
31. Expression of HCV envelope proteins and the serological utility of the anti-E2 immune response.
Lesniewski RR; Watanabe S; Devare SG
Princess Takamatsu Symp; 1995; 25():129-37. PubMed ID: 8875617
[TBL] [Abstract][Full Text] [Related]
32. Cell fusion activity of hepatitis C virus envelope proteins.
Takikawa S; Ishii K; Aizaki H; Suzuki T; Asakura H; Matsuura Y; Miyamura T
J Virol; 2000 Jun; 74(11):5066-74. PubMed ID: 10799580
[TBL] [Abstract][Full Text] [Related]
33. Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells.
Basu A; Kanda T; Beyene A; Saito K; Meyer K; Ray R
J Virol; 2007 Apr; 81(8):3933-41. PubMed ID: 17287282
[TBL] [Abstract][Full Text] [Related]
34. Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding.
Klenk K; Roberts SR
Virus Res; 2002 Dec; 90(1-2):327-35. PubMed ID: 12457986
[TBL] [Abstract][Full Text] [Related]
35. Formation of bovine viral diarrhea virus E1-E2 heterodimers is essential for virus entry and depends on charged residues in the transmembrane domains.
Ronecker S; Zimmer G; Herrler G; Greiser-Wilke I; Grummer B
J Gen Virol; 2008 Sep; 89(Pt 9):2114-2121. PubMed ID: 18753220
[TBL] [Abstract][Full Text] [Related]
36. [Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins].
Goffard A; Lazrek M; Bocket L; Dewilde A; Hober D
Ann Biol Clin (Paris); 2007; 65(3):237-46. PubMed ID: 17502294
[TBL] [Abstract][Full Text] [Related]
37. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto- and transmembrane domains.
Lin X; Zhang Y; Bi S; Lu J; Zhao H; Tan W; Li D; Wang Y
Biochem Biophys Res Commun; 2009 Jul; 385(2):257-62. PubMed ID: 19464265
[TBL] [Abstract][Full Text] [Related]
39. Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a
Tong Y; Chi X; Yang W; Zhong J
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100619
[TBL] [Abstract][Full Text] [Related]
40. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
Ory DS; Neugeboren BA; Mulligan RC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11400-6. PubMed ID: 8876147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
